Module

Pathobiology of Non-Hodgkin’s Lymphoma: Recent Advances

Source: Lymphoma Annual Update 2005

Pathobiology of Non-Hodgkin’s Lymphoma: Recent Advances


Program Director: Julie M. Vose, MD

Faculty:

  • Randy Gascoyne, MD, FRCPC

CME CREDIT INFORMATION

Release Date: 08/30/05

Expiration Date: 08/29/06


Physicians: maximum of 1 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe genetic signatures associated with outcome and prognosis in NHL.

  • Understand key intracellular pathways associated with NHL.

  • Review advances in gene expression profiling of various NHL subtypes.


Content includes:

  • Pathobiology of Follicular Lymphoma
  • Cytogenetic profile of Follicular Lymphoma
  • The Role of Macrophages in Follicular Lymphoma
  • Extranodal MALT Lymphomas
  • FOXP Transcription Factors in MALT Lymphoma
  • Mantle Cell Lymphoma
  • Diffuse Large B-cell Lymphoma
  • Primary Mediastinal Large B-cell Lymphoma
  • Peripheral T-cell Lymphomas
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.